Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Inc is a biotechnology company which is focused on advancing innovative product opportunities in areas of large unmet needs such as constipation, gastrointestinal disorders, hyperuricemia, among others.
IPO Date: February 3, 2010
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $115.38M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.23 | 2.09%
Avg Daily Range (30 D): $0.03 | 4.90%
Avg Daily Range (90 D): $0.04 | 4.85%
Institutional Daily Volume
Avg Daily Volume: 1.26M
Avg Daily Volume (30 D): 1.66M
Avg Daily Volume (90 D): 2.33M
Trade Size
Avg Trade Size (Sh.): 137
Avg Trade Size (Sh.) (30 D): 260
Avg Trade Size (Sh.) (90 D): 239
Institutional Trades
Total Inst.Trades: 7,583
Avg Inst. Trade: $1.93M
Avg Inst. Trade (30 D): $1.07M
Avg Inst. Trade (90 D): $1.89M
Avg Inst. Trade Volume: .17M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.59M
Avg Closing Trade (30 D): $1.18M
Avg Closing Trade (90 D): $2.18M
Avg Closing Volume: 252.11K
   
News
Apr 14, 2025 @ 6:19 PM
Ironwood Pharmaceuticals Stock Plunges, FDA Wants ...
Source: Vandana Singh
Dec 6, 2024 @ 12:00 PM
Beam Therapeutics Announces Appointment of Sravan ...
Source: N/A
Jul 5, 2024 @ 10:31 AM
New Strong Sell Stocks for July 5th - Zacks Invest...
Source: N/A
May 10, 2024 @ 3:16 PM
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of...
Source: Zacks Equity Research
May 2, 2024 @ 2:01 PM
Earnings Preview: Ironwood Pharmaceuticals (IRWD) ...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.21 $-.23 $.01
Diluted EPS $-.21 $-.23 $.01
Revenue $ 317.68M $ 41.14M $ 90.55M
Gross Profit $ $ $
Net Income / Loss $ -32.34M $ -37.39M $ 2.26M
Operating Income / Loss $ 53M $ -29.11M $ 31.49M
Cost of Revenue $ $ $
Net Cash Flow $ -13M $ 19.93M $ .33M
PE Ratio